Add like
Add dislike
Add to saved papers

ED management of acute pyelonephritis in women: a cohort study.

Various treatment strategies are currently used in the management of acute pyelonephritis, with some patients being treated as inpatients and others as outpatients. To better describe the clinical course of patients with this condition and the management strategies of physicians treating these patients, a retrospective cohort study of febrile nonpregnant women presenting to the emergency department with clinical evidence of acute pyelonephritis was conducted. Acute pyelonephritis was defined as infected urine (> or = 7 white blood cells/high-power field and/or urine culture with > or = 10(4) colony-forming units [CFU]/mL) and fewer (> or = 37.8 degrees C) without other source. Between October 1990 and September 1991, 28 hospitalized and 83 nonhospitalized patients satisfied these criteria. Data were abstracted from hospital charts, and clinical outcomes were determined from chart reviews and telephone or mailed questionnaires. The hospitalized patients were significantly older (odds ratio [OR] = 1.07), had higher temperatures (OR = 6.12), and were more likely to have diabetes (OR = 10.57), genitourinary tract abnormalities (OR = 10.53), and vomiting (OR = 12.17) than the nonhospitalized patients. Sixty-six (80%) of the nonhospitalized patients were treated with a single dose of parenteral antibiotic (usually gentamicin or ceftriaxone) before discharge on oral antibiotics. Seventy-one (86%) were treated with oral trimethoprim-sulfamethoxazole. Follow-up was obtained for 75 (90%) of the nonhospitalized patients. Nine (12%) of the 75 returned because of symptoms of acute pyelonephritis, with 8 returning within 1 day of the initial visit. Seven of those returning were admitted. All responded to additional antibiotic therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app